In this work, we investigated the distribution of the Ca'+-dependent cell adhesion molecule, M-cadherin, in mouse limb muscle during normal development and regeneration. the surface of myotibres. All together. these observations suggest that M-cadherin is specifically involved in secondary myogenesis.
The formation of limb muscles in vertebrates results from a series of developmentally orchestrated cellular interactions involving myogenic precursor cells that originate from the lateral half of the somites (Ordahl and Le Douarin, 1992) . These cells migrate into the limb buds, where they condense into dorsal and ventral premuscle masses, which then cleave to form individual muscles (Chevallier et al., 1977; Christ et al., 1977) . Within these pre-muscle masses, myogenic precursors divide, differentiate and fuse to form multinucleated myotubes that give rise to adult limb myotibres. Although all the myoblasts have the same embryonic origin, they soon form two sub-populations corresponding to two discrete steps of myogenesis, for which anatomi-cal studies have provided detailed description and timing (Kelly and Zacks, 1969; Ashmore et al., 1972; Landmesser and Morris, 1975; Ontell, 1977; McLennan, 1983; Ontell and Kozeka, 1984; Ross et al., 1987; Ontell et al., 1988; Harris et al., 1989a; Ashby et al., 1993) . The so-called primary myoblasts are first withdrawn from the cell cycle and fuse to form primary myotubes, which shape the position and orientation of individual muscles by their tendinous insertion. Primary myotubes, which are initially electrically coupled by gap junctions and associated in clusters, are progressively separated by individual laminin-rich basal lamina sheaths. At this stage, a second population of myoblasts, which has remained quiescent during the first wave of myogenesis, proliferates under the basal lamina of primary myotubes. These secondary myoblasts adhere to the plasma membrane of primary myotubes without fusing with them, whereas those situated close to the primary myotube-nerve contacts 0925-4773/95/W9.50 0 1995 Elsevier Science lreland Ltd. All rights reserved SSDI 0925-4773(94)00327-J start to fuse among each others forming secondary myotubes (Ontell, 1977; . These myotubes continue to grow under the basal lamina of primary myotubes, by fusion of more secondary myoblasts at both extremities, until they reach the tendons. They then separate from primary myotubes by the individualization of their own basal lamina. This process continues until neonatal life. Eventually, all limb muscles become populated by individual myofibres which have their own basal lamina. A third population of undifferentiated myogenic cells, known as satellite cells, remains quiescent, apposed to the myolibres underneath their basal lamina (Mauro, 1961) . These adult myoblasts are activated in response to muscle trauma or damage and promote the repair of injured muscles (Mauro, 1979) .
These anatomical observations suggest that cellmatrix and cell-cell interactions play a fundamental role in all the steps of muscle development and muscle repair. Accordingly, a number of cell receptors for the extracellular matrix molecules and of cell adhesion molecules (CAMS) are expressed during specific phases of myogenesis, with finely regulated levels and subcellular localization. Cell receptors for the extracellular matrix molecules include the integrins (w3pI (Von der Mark et al., 1991) and o&r (VLA4) (Rosen et al., 1992) , the tibronectin receptor asPl (Lakonishok et al., 1992; Enomoto et al., 1993) and the laminin receptor (Y$, (Song et al., 1992; George-Weinstrein et al., 1993; Bozyczko et al., 1989) . Cell adhesion molecules (CAM) include N-CAM (Rieger et al., 1985; Covault and Sanes, 1986; Barton et al., 1988; Tassin et al., 1991) and, specifically, its polysialilated isoform (Fredette et al., 1993) , VCAM-1 and its counter receptor VLA4 (Rosen et al., 1992) and N-cadherin (Hahn and Covault, 1992; Fredette et al., 1993; Cifuentes-Diaz et al., 1994a,b) . N-CAM is expressed throughout primary and secondary myogenesis, but specific accumulations of a polysialylated lipid-linked isoform appear between primary and secondary myotubes during their separation by proper basal lamina. N-cadherin is predominantly expressed during primary myogenesis (Fredette et al., 1993; Cifuentes-Diaz et al., 1994a) . It first accumulates at the areas of contact between primary myoblasts and primary myotubes, then between primary and secondary myotubes and disappears during myotube separation (Hahn and Covault, 1992; Fredette et al., 1993) . VLA-4 is expressed both on primary and secondary myotubes. while VCAM-I, which binds to VLA4, is restricted to secondary myoblasts and myotubes (Rosen et al., 1992) . VLA-4 as well as N-CAM but not the N-CAM polysialylated form continue to be expressed on nonactivated satellite cells in adult muscle (Figarella et al., 1990; Rosen et al., 1992; Cifuentes-Diaz et al., 1994b) . N-CAM, VLA4NCAM-1 and N-cadherin have been shown to participate to myoblast adhesion, which is a prerequisite for myoblast fusion (Knudsen et al., 1990a,b; Dickson et al., 1990; Mege et al., 1992; Rosen et al., 1992) .
The study of cadherin localization and role during muscle development deserves particular attention. Members of the cadherin family are Ca"+-dependent cell adhesion molecules sharing a high degree of amino acid sequence homology. Cadherins are very important for morphogenesis during development and for maintaining intercellular cohesion in adult tissues (Takeichi, 1991) . They mediate strong homophilic intercellular adhesion inducing a close association of cell membranes and the formation of intercellular adherent junctions (Mege et al., 1988; Gumbiner et al., 1988; Matsuzaki et al., 1990) and communicant gap junctions (Mege et al., 1988; Matsuzaki et al., 1990; Jongen et al.. 1991; Meyer et al., 1992) . These junctions, which mediate metabolic and electric coupling between adjacent cells, are thought to play important roles in myogenesis (Rash and Fambrough, 1973; Kalderon and Gilula, 1979; Ross et al., 1987; Mege et al., 1994) . Cadherins have also been shown to induce cell sorting-out in vitro (Nose et al., 1988; Friedlander et al., 1989 ) and thus could be at the bases of cell segregation and cell population individualisation in vivo. At least five other members of the cadherin family apart from N-cadherin have been detected in developing muscle: chicken R-cadherin (Inuzuka et al., 1991) , T-cadherin (Ranscht and DoursZimmermann, 1991) and B-cadherin (Napolitano et al., 1991) , Xenopus EP-cadherin (Levi et al., 1991) and mouse M-cadherin (Donalies et al., 1991) . M-cadherin cDNA has been isolated and cloned from a Cz mouse muscle cell line cDNA library (Donalies et al., 1991) . The M-cadherin transcript has been found specifically in developing skeletal muscle as early as the myogenic markers myogenin and desmin (Moore and Walsh, 1993) . So far, little is known on the biochemical characterization of this protein, its tissular distribution, developmental regulation and even adhesive function. We report here the distribution of the M-cadherin protein in developing, adult and regenerating mouse limb muscle, as well as during secondary myogenesis in vitro. The restricted location of M-cadherin during secondary myogenesis suggests a specific role of M-cadherin in primary myotube/secondary myotube interactions.
Results

Immunoreactivity of the anti-M-cadherin untihodies
In order to characterize the specificity of the antibodies used for immunostaining, we performed immunoprecipitation and Western blotting experiments with both anti-peptide antibodies. Indeed, the antiFSlDKFTGRVYLNAT penta-decapeptide antibody (commercial) has been used previously (Donalies et al., 1990) C2, L4) or with the commercial anti-M-cadherin antibody (Cz, Commercial) (leg muscles El8, Commercial). (C) lmmunoblotting of El8 leg muscles and oesophagus extracts was carried out with the commercial antibody. h;lolecular weight markers ( x 10)) are indicated on the right of the gels. M-cadherin immunoreactive bands at 125 000 (-_) and 165 000 and 100 000 (-) are arrowed on the left of the gels. These three major species are consistently detected. bryonic development, corresponding to different steps of myogenesis according to the morphological description of Ontell and Kozeka (1984) and Ashby et al. (1993) . Anti-M-cadherin antibodies were applied on unfixed cryostat sections of foetal thigh muscles ranging from El2 to early post-natal life (P7). At E12, the myogenic precursors have condensed in the limb bud and individual muscles have formed in which primary myoblasts are fusing. The myogenic cells, primary myoblasts and myotubes, identified by their positive anti-desmin antibody staining on adjacent sections (not shown), were weakly and discontinuously labeled by the anti-M-cadherin antibodies ( Fig. 2A and A'). At E14, primary myotubes had increased in size and M-cadherin staining was weaker than at El2 ( Fig. 2B and B'). At E16, numerous myobtasts and smaller secondary myotubes had appeared in the vicinity of primary myotubes (Harris et al., 1989b) . At this stage, an overall increase of M-cadherin staining was noted throughout the muscle ( Fig. 2C and C'). M-cadherin immunoreactivity clearly outlined the surface of myotubes. Another striking change in M-cadherin staining was the appearance, at E16, of sharp accumulations of M-cadherin at myotube-myotube contact sites. At E18, secondary myogenesis was still going on in the muscle, composed of myoblasts and primary and secondary myotubes at very different stages of differentiation (Harris et al., 1989b) . M-cadherin staining sharply delineated the areas of contact between smaller myotubes or myoblasts and larger diameter myotubes still organized in clusters ( Fig. 2D and D'). In muscles from new-born mice (PO), the M-cadherin staining did not change significantly with respect to El8 (not shown). However, M-cadherin staining of muscle tibres was very weak at post-natal day 2 except at a few sites of contact between small myogenic cells and myotubes ( Fig. 2E and E') and was negative at post-natal day 7.
M-cadherin sub-cellular localization during secondary myogenesis in vivo
At E18, myotubes were arranged in clusters formed of a large diameter primary myotube and one or more less developed smaller secondary myotubes. M-cadherin immunostaining was homogeneously distributed on the sarcolemma of both large diameter and smaller diameter myotubes within clusters ( Fig. 3A and A' ). The insertion sites of secondary myotubes in primary myotubes, characterized by .invaginations of small diameter myotube membranes into large diameter myotubes (Duxson and Usson, 1989) , were much more intensively labeled. Staining accumulations were detected at the sites of contact between large diameter myotubes and mononucleated cells apposed to their surface. To further demonstrate that M-cadherin was specifically accumulated at the areas of contact between primary and secondary myotubes, a double staining with anti-Mcadherin antibodies and the anti-neonatal fast myosin isoform monoclonal antibody My32 was performed on E 16 leg muscles ( Fig. 3B-B " ). In these preparations, Mcadherin accumulations were only detected at the areas of contact between a My32 positive and a My32 negative myotube. M-cadherin accumulations were not seen between two My32 positive cells, suggesting that Mcadherin was specifically accumulated between a well differentiated myotube expressing neonatal fast myosin isoform, probably primary, and a younger myotube, likely to be a secondary myotube (Harris et al., 1989b; Wilson and Harris, 1993) . Double staining for Mcadherin and laminin was also performed on El6 leg muscles sections in order to reveal the basal lamina in formation around the clusters of myotubes. The observation of the preparations at the conventional fluorescent microscope revealed apparently continuous laminin staining encircling clusters of two or more myotubes of different size clearly appearing under a unique basal lamina (not shown). M-cadherin immunoreactivity appeared accumulated at the areas of contact between myotubes encircled by the same basal lamina. Analysis of these preparations with a confocal microscope confirmed that M-cadherin was accumulated at the areas of contact between myotubes (Fig. 3C-C ") . However, the anti-laminin staining on these 0.5 pm optical sections appeared discontinuous. Nevertheless, M-cadherin accumulations were exactly and exclusively located in these laminin negative zones of apposition between myotubes likely to be primary and secondary myotubes not yet separated by a basal lamina. However, in these preparations the resolution was not enough to unambiguously decide whether M-cadherin was also present at the boundary between mononucleated myogenic cells.
M-cadherin expression and localization in fusing secondary myoblasts in culture
We then studied the expression and cellular localization of the molecule during the differentiation of neonatal mouse myoblasts in vitro (Fig. 4) . Proliferating (A and A' ), M-cad&in staining was scarce and discontinuous at the surface of myogenic cells (arrow). At El4 (B and B'), a very low level of immunoreactivity was detected at the surface of myotubes. In contrast, at El6 (C and C') and El8 (D and D'), M-cadherin immunostaining was intense at the surface of myotubes and was specifically accumulated at the areas ofceh-ceil contact (arrows). At P2 (E and E'), these accumulations were still detectable but had disappeared at P7. Bars: A-C' = 20 pm; D-E' = 40 ctm.
myoblasts, shortly after plating at low density, were very weakly, or not stained at all, with the anti-M-cadherin antibodies ( Fig. 4A and A' ). After induction of differentiation, M-cadherin became specifically accumulated at the areas of contact between aligned myoblasts and newly formed oligonucleated myotubes in the process of fusion (Fig. 4B-D' ). Already at this time and later on during differentiation, myotubes frequently adhered to other myotubes, more often by their endpoints. Mcadherin was accumulated at the areas of contact between these myotubes ( Fig. 4E and E' ). In older cultures, these examples of adhering and non-fused myotubes were less frequent and accumulations of Mcadherin disappeared (Fig. 4F and F') . At all the stages of in vitro secondary myogenesis studied, the free surface of myogenic cells, myoblasts and myotubes appeared weakly positive for M-cadherin while tibroblasts that were always present in the cultures were negative for M-cadherin.
M-cadherin expression in adult normal and regenerating muscle
In normal adult leg muscles, M-cadherin immunoreactivity was detected in intramuscular vessels and capillaries as well as on a few mononucleated cells but not on myotibres ( Fig. 5A and B) . To know whether Mcadherin was re-expressed during regeneration of adult muscle, we studied the distribution of M-cadherin after muscle injury and during subsequent muscle regeneration in adults. Muscle regeneration was experimentally induced by autotransplantation of the EDL muscle of young adult mice (Carlson and Gutmann, 1975; Alameddine et al., 1991) . Anti-M-cadherin immunostaining was performed 1, 3, 7, 14, 30 and 60 days after muscle damage. Autotransplantation resulted in extensive necrosis of the muscle fibres occupying the centre of EDL with the preservation of a peripheral rim of intact myofibres that survived ischemic injury. In this model, progression of the degeneration and regeneration processes is characterized by a centripetal gradient that follows revascularization. By day 3 after injury, two separate zones could be distinguished: a superficial rim of 3-5 muscle fibres thickness of normal appearance, and the most central part occupied by necrotic muscle tibres some of which were invaded by infiltrating cells. Three days after injury, the general level of M-cadherin staining appeared slightly increased, specially at the surface of some mononucleated cells (not shown). Seven days after injury, the central part of the EDL is mainly composed of regenerating myotibres still incorporating more myoblasts, with a few necrotic fibres. M-cadherin immunofluorescent staining performed at this time ( Fig.  5C and D) revealed M-cadherin positive mononucleated cells, localized outside the laminin-positive basal lamina, but failed to show sarcolemmal labeling on regenerating myofibres. Moreover, no accumulation of staining was observed at any area of cell-cell contact. Regeneration is completed by two weeks after injury and the regenerating myofibres increase their diameter thereafter but still have central nuclei. We did not detect any sarcolemmal M-cadherin staining at any later stage of regeneration.
Discussion
M-cadherin is a recently discovered cadherin, for which cDNA has been cloned from a mouse muscle cell line (Donalies et al., 1991) . The messenger RNA has been found to be expressed very early in developing mouse skeletal muscle and to persist during myogenesis (Moore and Walsh, 1993) . However, the distribution of M-cadherin protein in developing embryos and in the adult tissues has not been documented so far. In the present study, using anti-M-cadherin peptide antibodies for immunofluorescent staining, we examined the localization of the M-cadherin protein during the differentiation of mouse skeletal muscle in vivo and in vitro. We related our observations to the histological descriptions of the different steps of muscle morphogenesis which have been particularly well documented for chicken, rat and mouse leg muscle development, providing the first insight in the search of the role and function of this molecule. We found that: (1) M-cadherin was specifically accumulated at the areas of contact between primary and secondary myotubes during secondary myogenesis, (2) M-cadherin was expressed, during secondary myogenesis in vitro, by prefusing myoblasts and by myotubes and was concentrated at the areas of contact between myogenic cells.
The assessment of specificity of the anti-peptides antibodies used in this study was mainly based on the obser- In regenerating muscle, no sarcolemmal M-cadherin accumulations at myoblast-myotube or myotube-myotube contact sites were observed. M-cadherin mononucleated cells (arrow heads) were much more numerous than in normal muscle and were localized outside the basal lamina evidenced by anti-laminin antibody (C) Bar = 50 pm.
vation that, while directed against two different regions of the molecule, both antibodies produce a similar immunostaining pattern on muscle frozen sections. Furthermore, if the commercial antibody did not immunoprecipitate any material in cell extracts, the L4 antibody immunoprecipitates in C, cell extracts a molecule of molecular weight 125 000, which is an expected size for M-cadherin (Donalies et al. 1990) . A band around 100 000 was also specifically immunoprecipitated by this antibody. This band could correspond to a proteolyzed or cleaved extracellular domain of the cadherin. Indeed, a corresponding cleaved extracellular domain has been shown to occur naturally in vivo for N-cadherin (Grunwald, 1993). Western blotting confirmed that both antibodies recognize molecules of the same molecular weight both in CZ and in embryonic muscle extracts. In addition, they label a higher molecular weight molecule (165 000), the nature of which is unknown. For Ncadherin, a molecule of similar molecular weight, although of undetermined nature, is specilically produced by N-cadherin cDNA transfected fibroblasts but not by untransfected cells (Matsuzaki et al., 1990) . The exact nature of the three M-cadherin immunoreactive bands of molecular weights 165 000, 125 000 and 100 000 will need further biochemical studies to be clearly elucidated, but these bands likely reflect the existence of different M-cadherin isoforms. M-cadherin immunoreactivity was detected at low levels in limb muscles from the beginning of fusion of primary myoblasts (E12) until the end of primary myogenesis (E14). During the whole period of primary myogenesis, M-cadherin did not appear accumulated at areas of cell-cell contact. Similarly, M-cadherin immunostaining was very weak and diffuse in the myotome at ElO, El2 and E14, while it appeared accumulated at the areas of myotube-myotube contact at El6 (data not shown). The level of M-cadherin immunoreactivity in developing hind limb muscle drastically increased at E16, which corresponds to the onset of secondary myogenesis (Ontell and Kozeka, 1984; Ashby et al., 1993) . Concomitantly, the subcellular localization of M-cadherin changed from a diffuse distribution in the muscle masses to a clear sarcolemmal location. Moreover, M-cadherin became strongly concentrated at areas of cell-cell contact, which may suggest an active involvement in cell adhesion. The high level of immunoreactivity, sarcolemmal localization and cell-cell contact accumulations of M-cadherin persist during the entire time course of secondary myogenesis and disappear in early post-natal life. These observations suggest that M-cadherin may specifically be involved in secondary myogenesis.
The expression of the protein in leg muscle is in total agreement with the detection of messenger RNA by Northern blotting during rat leg muscle development (Pouliot et al., 1994) , taking into account a 1.5-2 days delay between mouse and rat muscle development (Ross et al., 1987) . Indeed, M-cadherin transcript was undetectable at El4 and low at the beginning of primary myogenesis (El5 in the rat). Then, the level of mRNA increased to reach a maximum at the beginning of secondary myogenesis (El 8, which is comparable to El6 in the mouse) in agreement with the apparent increase in protein at this stage in the mouse. Both Pouliot's results and ours are in overall agreement with previous localization of M-cadherin mRNA in mouse embryos by in situ hybridization (Moore and Walsh, 1993) . M-cadherin proteins and transcripts were detected roughly at the same stages, as early as the beginning of primary myogenesis, E9.5-El0 in the myotome, E11.5, El2 in mouse forelimb buds, respectively. However, mRNA was not detected by in situ hybridization after E17.5 in the mouse leg muscle, while the protein in the mouse and the transcripts detected by Northern blots in the rat remained detectable until the end of secondary myogenesis. These discrepancies may be due to a difference in sensitivity of the different techniques to detect low levels of transcripts.
In culture, new-born mouse myoblasts do express Mcadherin at their surface. These cells originate from the in vitro division of myogenic cells, that were not fused yet at birth, and are considered to be representative of secondary myoblasts. M-cadherin was almost undetectable on proliferating isolated myoblasts and became highly accumulated at the areas of contact between aligned, prefusing, myoblasts. It was also accumulated at the areas of contact between myoblasts and myotubes and between myotubes. These results show that Mcadherin expression is not induced in myotubes after fusion but instead starts on mononucleated fusioncompetent cells. Thus, M-cadherin-mediated adhesion as well as N-cadherin-mediated adhesion (Knudsen at al., 1990b; Mege et al., 1992) may be involved in the Ca2+-dependent adhesion step which precedes myoblast membrane fusion in the cascade of events leading to myotube formation. However, the pattern of expression of M-cadherin presents striking differences with that of N-cadherin, which is predominantly expressed during primary myogenesis and down-regulated during secondary myogenesis in chicken (Hahn and Covault, 1992; Cifuentes-Diaz et al., 1994a) . The pattern of expression of these molecules is very likely to be conserved from avian to mammals, given the fact that the morphological aspects of myogenesis are very similar between the two species. Thus, the putative complementary pattern of expression of these two molecules suggests that Ncadherin may mediate myoblast adhesion during the first wave of myoblast fusion and at a lower degree during the second wave, while M-cadherin may specifically be involved in the second wave of myoblast fusion.
At El6 and E18, myotubes were arranged in clusters of one primary myotube together with one or a few secondary myotubes and/or myoblasts under a unique basal lamina. M-cadherin was specifically accumulated within these clusters at the sites of contact between secondary myotubes and myoblasts and their primary myotube scaffolds. The sarcolemma of both primary and secondary myotubes was clearly M-cadherin positive, even in areas not engaged in cell-cell contacts, indicating that both types of myotube express the molecule. All together, these observations clearly show that, during secondary myogenesis, M-cadherin is accumulated at the sites of insertion of secondary myotubes onto primary myotubes. They suggest that this molecule, as previously suggested for the adhesion molecules VCAM-1 and VLA4 (Rosen and Sanes, 1992) , may also specifically mediate the attachment of secondary myoblasts and myotubes to primary myotubes. These myotubes are linked by adherent (adherens) and communicant (gap) junctions (Ross et al., 1987 ) the formation of which may be dependent upon Mcadherin. However, M-cadherin-mediated adhesion between these two types of myotubes would not be followed by cell fusion, since these two types of myotubes never fuse together (Duxson and Usson, 1989) .
Further supporting a specific involvement of M-cadherin in secondary myogenesis, is its downregulation shortly after birth and its absence on the surface of adult myofibres; even though we can not totally exclude the persistent labeling of very few M-cadherinpositive satellite cells in 2-month-old mouse muscles, as it has been found by Irintchev, et al. (1994) . Three days after experimentally induced injury, we detected Mcadherin immunoreactivity at the surface of mononucleated cells in agreement with mRNA accumulation (Moore and Walsh, 1993) . These positive cells could be activated satellite cells. However, most of them are localized outside the laminin-rich muscle basal lamina and are more likely to be libroblasts, endothelial and/or infiltrating cells. The labeling of intramuscular blood vessels and nerves, consistently found in normal and injured muscle, was not mentioned by Irintchev et al. (1994) and such discrepancies may be explained by differences in the antibodies used and will need further study. Another divergent finding is the absence of sarcolemmal accumulation of M-cadherin at sites of cellcell contact at all examined stages of regeneration. These different findings may be explained by the use of a myogenic cell line for injection in the regeneration experiments of Irintchev and colleagues. Indeed, previous work has reported that the proliferation, differentiation and expression of cell adhesion molecules of this kind of cells are not always properly regulated when injected in regenerating muscle (Morgan et al., 1992) . Thus, we believe that the absence of cell-cell contact accumulation of M-cadherin we observed during normal muscle regeneration suggests an absence of involvement of this cadherin in an active adhesion during adult regenerative myogenesis. Regeneration of skeletal muscle is generally viewed as a recapitulation of myogenesis taking place during normal development of the muscle. However, adult regenerative myogenesis is not as well anatomically documented as primary and secondary myogenesis occurring during development. Our observations suggest that adult regenerative myogenesis would be more similar to primary myogenesis than to secondary myogenesis.
Experimental procedures
Animals and surgical procedures
All the mice were from the 129 ReJ strain bred in our laboratory. Embryos were obtained from timed pregnancies. The day following overnight mating was designated Day 0 (EO). Dated pregnant females were etherized at day 10, 12, 14, 16 and 18 and foetuses were removed. Leg muscles were dissected out from foetuses or neonatal mice and directly frozen without fixation in isopentane cooled by liquid nitrogen.
For the preparations of regenerating muscle, orthotopic autotransplantation of extensor digitorum longus (EDL) muscles of 18 adult male mice (8 weeks) was carried out as previously described (Carlson and Gutmann, 1975; Alameddine et al., 1991) . Briefly, the proximal tendon of the EDL muscle was cut and the muscle was pulled out distally until it had been completely removed from its bed. It was then returned to its original site, the cut tendon ends were sutured and overlying muscle and skin were closed separately. Regenerating muscles were removed 1, 3, 7, 14, 30 and 60 days (n = 3 for each time) after surgery. Muscle blocks were frozen as embryonic muscles.
Cell culture
Primary cultures of neonatal mouse muscle cells were prepared as previously described (Tassin et al., 1991) . Leg muscles from neonatal mice were dissected out and dissociated by trypsin. Cells were plated in tissue culture dishes in presence of Dulbecco's medium supplemented with 10% horse serum, 10% foetal calf serum (Gibco) and 1.25% chick embryo extract (Flow Laboratories). Cells that did not attach after 1 h, mostly myoblasts, were plated at lo4 cells on gelatine-coated 35 mm dishes and grown in the same medium at 37°C in 7.5% C02. Four days later, cells were changed with differentiation medium, i.e. Dulbecco's medium supplemented with 10% horse serum, 1.25% chick embryo extract.
The CZ myoblastic cell line derived from 2-month-old normal mice (Yaffe and Saxel, 1977) was cultured in Dulbecco's medium with 20% foetal calf serum.
4.3, Anti-M-cadherin antibodies
Two distinct rabbit anti-mouse M-cadherin polyclonal antibodies, raised against synthetic peptides deduced from the EC1 region of M-cadherin, were used for this study. The first one (commercial) was raised against the synthetic penta-decapeptide FSIDKFTGR-VYLNAT (Donalies et al., 1991) and purchased from Santa-Cruz BioTechnology Inc. We raised the second one (L4) against the synthetic hepta-decapeptide FRL-RAFALDLLGGSTLED.
The peptide was synthesized and coupled to ovalbumin (OVA) with glutaraldehyde at 12 moles of peptide per mole OVA by Neosystem S.A. Two rabbits were injected once with 500 rg of peptide in complete Freund's adjuvant (Gibco) and re-injected with the same quantity of peptide in incomplete adjuvant every three weeks (three injections). Rabbits were bled every two weeks and sera were tested by ELISA for their anti-peptide reactivity. IgGs were purified on a protein A-Sepharose 4B affinity column (Sigma). Both rabbits produced anti-peptide antibodies but only one of them produced IgGs which labeled CZC12 myogenic cells by immunofluorescence.
Immunojluorescent staining
Cell cultures were washed with PBS (Phosphate Buffered Saline) and fixed in PBS containing 3% formaldehyde for 30 min, then washed three times in PBS, 0.1 M glycine. After an incubation of 1 h in blocking solution (PBS, Bovine serum albumin (BSA) 3%), fixed cultures were incubated for 1 h in blocking solution containing the anti-M-cadherin antibodies (dilution l/30). They were then washed and incubated with a fluorescein antirabbit IgG conjugate (ICN) diluted l/l50 in the blocking solution. After washing, cultures were then mounted in glycerol-Moviol (Calbiochem) and observed with a fluorescence microscope (Axiophot, Zeiss).
Tissue section immunostaining procedures were performed as described elsewhere (Cifuentes-Diaz et al, 1994a) . Frozen embryonic and adult muscles were serially cut at -28°C. Cryostat sections (6 pm) were directly incubated for 1 h with the anti-M-cadherin antibodies diluted 1:50 in blocking solution, washed in PBS, then incubated for 1 h with fluorescein conjugated antirabbit IgGs (dilution 1: 100; Tago). For anti-M-cadherin and anti-laminin double staining, sections already stained with the anti-M-cadherin antibody as described above were incubated with a polyclonal anti-laminin antibody (dilution 1:250; Sigma), then with an antirabbit antibody coupled to rhodamine (dilution 1:200; Biosys.). Single staining for both molecules were carried out in parallel with the same reagents and gave similar staining. For anti-M-cadherin and anti-myosin double staining and anti-M-cadherin/anti-desmin staining, sections were incubated with a mixture of the anti-Mcadherin antibody and of the monoclonal anti-neonatal fast myosin antibody My 32 (dilution 1:lOOO; Sigma) or of the monoclonal anti-desmin antibody (dilution 1:50; Sigma), then reacted with a mixture of fluorescein conjugated anti-rabbit IgGs and rhodamine conjugated anti-mouse IgGs (Biosys). All these antibodies were diluted in blocking solution and incubated for 1 h at room temperature. The specificity of the staining was assessed by the omission of the primary antibody or the use of pre-immune IgGs and by preincubating the specific antibodies with the antigenic peptides. Sections were mounted and observed with a conventional fluorescence microscope or with a confocal laser scanning microscope (BioRad MRC-600, mounted on an Optiphot II Nikon microscope) as described previously (Mege et al., 1992) .
Irnmunoprecipitation, gel electrophoresis and
Western blotting C2 cells were grown to confluence and incubated overnight in 35S methionine containing medium (250 PCi per 60 mm dish). After washing four times in PBS, the cells were extracted in 0.4% SDS (Sodium Dodecyl Sulfate), 2% NP-40,0.5% Deoxycholate, 150 mM NaCl, 2mM EDTA and 1: 1000 aprotinin. The extracts were incubated with antibodies coupled to protein A-Sepharose beads (Sigma) for 6 h at 4°C. The beads were washed in RIPA buffer (10 mM Tris pH 7.5,5 mM EDTA, 1% NP-40, 1% Deoxycholate, 0.1% SDS), then in RIPA buffer plus 0.5 M NaCl and in 10 mM Tris (pH 7.4), 150 mM NaCl and 2 mM EDTA. Then, the beads were boiled in Laemmli sample buffer and proceeded for SDS-PAGE.
For Western blotting, frozen tissue samples or scraped cell cultures were directly homogenized in 0.1 M phosphate-buffered saline, pH 7.4, (PBS) containing 0.3% SDS, 1: 1,000 aprotinin and 10 &ml DNAase, centrifuged at 100 000 g for 5 min and the protein concentration of the supernatants determined using a Lowry modified method (Smith et al., 1985; BCA kit, Pierce, Rockford, 11) . Aliquots containing 100 gg of protein were processed for immunoblotting as previously described (Ml?ge et al., 1992) except for the detection. M-cadherin immunoreactive material was detected by sequential incubation with the anti-M-cadherin polyclonal antibodies (dilution l/20 in PBS containing 3% BSA) and peroxidase conjugated rabbit anti-mouse IgGs, revealed by chemioluminescence with the ECL kit (Amersham France S.A., Les Ulis, France).
